Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Leung, Elaine Lai Han ^a   Fiscus, Ronald R ^b,c   Tung, James W ^b   Tin, Vicky Pui Chi ^a   Cheng, Lik Cheung ^d   Sihoe, Alan Dart Loon ^d   Fink, Louis M ^b   Ma, Yupo ^b,e   Wong, Maria Pik ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NEVADA CANCER INSTITUTE   (United States)

^c ROSEMAN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d QUEEN MARY HOSPITAL   (Hong Kong)

^e STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CISPLATIN; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; BMI1 PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; ONCOPROTEIN; PEPTIDE; POU5F1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR CELL; TUMOR XENOGRAFT; AGED; ANIMAL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOBLOTTING; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; XENOGRAFT;

MUS MUSCULUS;

AGED; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 78649522166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014062     Document Type: Article

References (48)

1. Dick JE (1994) Future prospects for animal models created by transplanting human haematopoietic cells into immune-deficient mice. Res Immunol 145: 380-384.
2. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313.
3. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514.
4. Ma S, Chan KW, Hu L, Lee TK, Wo JY, et al. (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556.
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumor initiating cells. Nature 432: 396-401.
7. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL (2008) CD44+ CD24(2) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98: 756-765.
8. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties. Cancer Res 65: 5506-5511.
9. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, et al. (2003) Stem cells. Setting standards for human embryonic stem cells. Science 300: 913-916.
10. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
11. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, et al. (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637.
12. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071.
13. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106: 16281-16286.
14. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE (2008) Drugselected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3: e3077.
15. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, et al. (2009) The role of CD133 in the identification and characterisation of tumor-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg.
16. Basak SK, Veena MS, Oh S, Huang G, Srivatsan E, et al. (2009) The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One 4: e5884.
17. Wu Y, Wu PY (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev.
18. Jaksch M, Munera J, Bajpai R, Terskikh A, Oshima RG (2008) Cell cycledependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 68: 7882-7886.
19. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
20. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumor formation by single human melanoma cells. Nature 456: 593-598.
21. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, et al. (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338.
22. Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, et al. (2009) Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 178: 48-55.
23. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
24. Alexander CM, Puchalski J, Klos KS, Badders N, Ailles L, et al. (2009) Separating stem cells by flow cytometry: reducing variability for solid tissues. Cell Stem Cell 5: 579-583.
25. Du L, Wang H, He L, Zhang J, Ni B, et al. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14: 6751-6760.
26. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.
27. Gai H, Leung EL, Costantino PD, Aguila JR, Nguyen DM, et al. (2009) Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int 33: 1184-1193.
28. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, et al. (2009) Oct4- induced pluripotency in adult neural stem cells. Cell 136: 411-419.
29. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, et al. (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114-1123.
30. Stuelten C, Mertins S, Busch J, Gowens M, Scudiero D, et al. (2010) Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel. Stem Cells.
31. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933.
32. Ma L, Lai D, Liu T, Cheng W, Guo L. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin (Shanghai) 42: 593-602.
33. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833.
34. Zeilstra J, Joosten SP, Dokter M, Verwiel E, Spaargaren M, et al. (2008) Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res 68: 3655-3661.
35. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, et al. (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8: 784-804.
36. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem 282: 3433-3441.
37. Bourguignon LY, Gilad E, Peyrollier K (2007) Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem 282: 19426-19441.
38. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16: 3074-3086.
39. Toole BP, Slomiany MG (2008) Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18: 244-250.
40. Toole BP, Slomiany MG (2008) Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat 11: 110-121.
41. Madjd Z, Mehrjerdi AZ, Sharifi AM, Molanaei S, Shahzadi SZ, et al. (2009) CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumors. Cancer Immun 9: 4.
42. Gutova M, Najbauer J, Gevorgyan A, Metz MZ, Weng Y, et al. (2007) Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One 2: e243.
43. Fasano M, Sabatini MT, Wieczorek R, Sidhu G, Goswami S, et al. (1997) CD44 and its v6 spliced variant in lung tumors: a role in histogenesis? Cancer 80: 34-41.
44. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, et al. (1994) Expression of CD44 in human lung tumors. Cancer Res 54: 1381-1387.
45. Takanami I, Takeuchi K, Naruke M (2000) Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma. Oncol Rep 7: 1065-1067.
46. Lam DC, Girard L, Suen WS, Chung LP, Tin VP, et al. (2006) Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers. J Thorac Oncol 1: 932-942.
47. Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, et al. (2007) Modern flow cytometry: a practical approach. Clin Lab Med 27: 453-468, v.
48. Tam IY, Chung LP, Suen WS, Wang E, Wong MC, et al. (2006) Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 12: 1647-1653.